Literature DB >> 23557632

Prion protein oligomer and its neurotoxicity.

Pei Huang1, Fulin Lian, Yi Wen, Chenyun Guo, Donghai Lin.   

Abstract

The prion diseases, also known as transmissible spongiform encephalopathies, are fatal neurodegenerative disorders. According to the 'protein only' hypothesis, the key molecular event in the pathogenesis of prion disease is the conformational conversion of the host-derived cellular prion protein (PrP(C)) into a misfolded form (scrapie PrP, PrP(Sc)). Increasing evidence has shown that the most infectious factor is the smaller subfibrillar oligomers formed by prion proteins. Both the prion oligomer and PrP(Sc) are rich in β-sheet structure and resistant to the proteolysis of proteinase K. The prion oligomer is soluble in physiologic environments whereas PrP(Sc) is insoluble. Various prion oligomers are formed in different conditions. Prion oligomers exhibited more neurotoxicity both in vitro and in vivo than the fibrillar forms of PrP(Sc), implying that prion oligomers could be potential drug targets for attacking prion diseases. In this article, we describe recent experimental evidence regarding prion oligomers, with a special focus on prion oligomer formation and its neurotoxicity.

Entities:  

Keywords:  neurotoxicity; oligomer; prion; transmissible spongiform encephalopathies

Mesh:

Substances:

Year:  2013        PMID: 23557632     DOI: 10.1093/abbs/gmt037

Source DB:  PubMed          Journal:  Acta Biochim Biophys Sin (Shanghai)        ISSN: 1672-9145            Impact factor:   3.848


  8 in total

1.  PrPSc Oligomerization Appears Dynamic, Quickly Engendering Inherent M1000 Acute Synaptotoxicity.

Authors:  Simote T Foliaki; Victoria Lewis; Abu M T Islam; Matteo Senesi; David I Finkelstein; Laura J Ellett; Victoria A Lawson; Paul A Adlard; Blaine R Roberts; Steven J Collins
Journal:  Biophys J       Date:  2020-06-10       Impact factor: 4.033

Review 2.  Toxicity and infectivity: insights from de novo prion formation.

Authors:  Brett T Wisniewski; Jaya Sharma; Emily R Legan; Emily Paulson; Stephen J Merrill; Anita L Manogaran
Journal:  Curr Genet       Date:  2017-08-30       Impact factor: 3.886

Review 3.  Neuroprotective effect and potential of cellular prion protein and its cleavage products for treatment of neurodegenerative disorders part I. a literature review.

Authors:  Emily Dexter; Qingzhong Kong
Journal:  Expert Rev Neurother       Date:  2021-09-02       Impact factor: 4.287

4.  The Biological Function of the Prion Protein: A Cell Surface Scaffold of Signaling Modules.

Authors:  Rafael Linden
Journal:  Front Mol Neurosci       Date:  2017-03-20       Impact factor: 5.639

Review 5.  The role of astrocytes in prion-like mechanisms of neurodegeneration.

Authors:  Phillip Smethurst; Hannah Franklin; Benjamin E Clarke; Katie Sidle; Rickie Patani
Journal:  Brain       Date:  2022-03-29       Impact factor: 13.501

Review 6.  Single-chain fragment variable passive immunotherapies for neurodegenerative diseases.

Authors:  Liang Huang; Xiaomin Su; Howard J Federoff
Journal:  Int J Mol Sci       Date:  2013-09-17       Impact factor: 5.923

7.  Unique Properties of the Rabbit Prion Protein Oligomer.

Authors:  Ziyao Yu; Pei Huang; Yuanhui Yu; Zhen Zheng; Zicheng Huang; Chenyun Guo; Donghai Lin
Journal:  PLoS One       Date:  2016-08-16       Impact factor: 3.240

Review 8.  What Is Our Current Understanding of PrPSc-Associated Neurotoxicity and Its Molecular Underpinnings?

Authors:  Daniel Hughes; Mark Halliday
Journal:  Pathogens       Date:  2017-12-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.